本页面由Tiger Trade Technology Pte. Ltd.提供服务

AC Immune SA

2.55
-0.0200-0.78%
盘后:2.550.00000.00%16:10 EDT
成交量:23.19万
成交额:59.32万
市值:2.60亿
市盈率:-4.84
高:2.61
开:2.57
低:2.50
收:2.57
52周最高:4.00
52周最低:2.10
股本:1.02亿
流通股本:3,918.55万
量比:0.89
换手率:0.59%
股息:- -
股息率:- -
每股收益(TTM):-0.5264
每股收益(LYR):-0.8828
净资产收益率:-78.53%
总资产收益率:-16.04%
市净率:6.13
市盈率(LYR):-2.89

数据加载中...

2026/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/13

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/30

SEC问询函

Form CORRESP - Correspondence
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/20

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities